Belfast Trust was the top UK recruiter to DARS (A phase III randomised multicentre study of dysphagia optimised intensity modulated radiotherapy (DoIMRT) versus standard intensity modulated radiotherapy (SIMRT) in head and neck cancer.) Belfast recruitment was above the original local target and the site was commended by the study co-ordinator. Dr Keith Rooney, the local Principal Investigator, acknowledged how excellent team work had contributed to local success. We wish to thank all the patients taking part in this study.
Posted in Uncategorized.